FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,684 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 47400 - 47600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.203.jsonBRCA1active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.204.jsonBRCA2active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.205.jsonBRCA1 Testingactive2023-06ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.207.jsonEpithelial Ovarian Canceractive2024-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.208.jsonPrimary Peritoneal Canceractive2022-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.209.jsonFallopian Tube Canceractive2022-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.210.jsonMultigene Panelactive2023-07ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.211.jsonBRCA1 and BRCA2active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.212.jsonBRCA1 and BRCA2 Testingactive2023-06ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.213.jsonBRAF V600active2022-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.214.jsonBRAF V600 Testingactive2023-04ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.215.jsonColorectal Canceractive2024-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.216.jsonBRAF V600 Mutation Statusactive2022-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.217.jsonCancer Stage Iactive2024-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.218.jsonHead and Neck Canceractive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.219.jsonMalignant Melanoma of Skinactive2022-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.220.jsonBrain Canceractive2022-07ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.221.jsonWaldenstrom Macroglobulinemiaactive2024-08ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.222.jsonHigh Emetic Risk Intravenous Antineoplastic Agentactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.223.jsonModerate Emetic Risk Intravenous Antineoplastic Agentactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.224.jsonDocetaxel Injectableactive2024-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.225.jsonCyclophosphamide Injectableactive2022-09ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.226.jsonLAG 3 Inhibitoractive2024-11ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.233.jsonChemotherapy Administrationactive2024-01ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.240.jsonPathological N Stage N3cactive2024-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.241.jsonAudio Visual Telehealth Encounteractive2025-01ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.242.jsonModerate or High Emetic Risk Oral Antineoplastic Agentactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.243.jsonMinimal to Low Emetic Risk Oral Antineoplastic Agentactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.244.jsonCopanlisib Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.245.jsonIsatuximab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.246.jsonLoncastuximab tesirine Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.247.jsonMargetuximab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.248.jsonMirvetuximab soravtansine Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.249.jsonTafasitamab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.250.jsonTeclistamab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.251.jsonTisotumab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.252.jsonAsparaginase Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.254.jsonBelantamab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.255.jsonDostarlimab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.256.jsonMosunetuzumab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.257.jsonTremelimumab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.258.jsonIndication for Dexamethasoneactive2025-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.260.jsonIndication for Olanzapineactive2025-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.261.jsonIndication for Dexamethasoneactive2025-04ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.263.jsonIndication for Olanzapineactive2025-04ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.264.jsonPrednisoneactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.265.jsonAs Needed PRNactive2025-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.266.jsonAmivantamab Injectableactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.200.jsonDoxorubicinactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.201.jsonEpirubicinactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.202.jsonCapecitabineactive2023-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.203.jsonCyclophosphamideactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.204.jsonInjectable Fluorouracilactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.205.jsonMethotrexateactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.206.jsonTrastuzumab and Biosimilarsactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.207.jsonHER2 Presence in Tissueactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.208.jsonCarboplatinactive2020-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.209.jsonDepression Screening for Adultactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.210.jsonLong Acting Opioidsactive2020-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.211.jsonHigh Fiber Supplement or Diet Educationactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.212.jsonDexamethasoneactive2021-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.213.jsonOlanzapineactive2021-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.214.jsonPancreatic Canceractive2020-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.215.jsonAudio Visual Telehealth Encounteractive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.216.jsonTelephone Encounteractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.217.jsonTelehealth Emergency Department or Initial Inpatientactive2024-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.218.jsonDyspnea Assessmentactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.219.jsonNausea or Vomiting Assessmentactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.220.jsonKarnofsky Performance Statusactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.221.jsonReferral to Hospice Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.222.jsonReferral to Palliative Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.223.jsonPalliative Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.224.jsonEnrollment in Hospice Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.225.jsonAdvance Directive Including Durable Power of Attorney or Instructionalactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.229.jsonMinimal Emetic Risk Intravenous Antineoplastic Agentactive2025-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.232.jsonEpithelial Ovarian Canceractive2023-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.233.jsonPrimary Peritoneal Canceractive2022-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.235.jsonBRCA2 Testingactive2023-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.236.jsonMultigene Panelactive2023-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.237.jsonBRCA1 Testingactive2023-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.238.jsonFirst Line Drug Therapy for Metastatic Colorectal Canceractive2022-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.239.jsonBRAF V600 Testingactive2022-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.240.jsonCancer Stage 4active2022-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.241.jsonCancer Stage M1active2024-12ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.242.jsonHigh Emetic Risk Intravenous Antineoplastic Agentactive2022-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.243.jsonModerate Emetic Risk Intravenous Antineoplastic Agentactive2024-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.245.jsonAntiemetic Agentactive2025-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.247.jsonIndication for Dexamethasoneactive2025-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.249.jsonIndication for Olanzapineactive2025-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.2074.1.1.3.jsonRace Category Excluding Nullsactive2024-06ushl7oid
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.1002.77.jsonCodeineactive2024-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.1004.13.jsonDihydrocodeineactive2024-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.1004.14.jsonNalbuphineactive2020-03ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4009.jsonMalignant Intracranial Neoplasmactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4010.jsonMalignant Intracranial Neoplasmactive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4015.jsonSTEMIactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4016.jsonSTEMIactive2019-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4017.jsonSTEMIactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4019.jsonFibrinolytic Therapyactive2023-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4023.jsonCerebral Vascular Lesionactive2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4024.jsonCerebral Vascular Lesionactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4025.jsonCerebral Vascular Lesionactive2019-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4026.jsonClosed Head and Facial Traumaactive2019-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4028.jsonAortic Dissection or Ruptured Aortic Aneurysmactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4029.jsonAcute Peptic Ulceractive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4030.jsonAcute Peptic Ulceractive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4031.jsonAcute Peptic Ulceractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4032.jsonDementia and Related Intracranial Pathologiesactive2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4033.jsonDementia and Related Intracranial Pathologiesactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4034.jsonActive Bleeding or Bleeding Diathesis, Excluding Mensesactive2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4035.jsonActive Bleeding or Bleeding Diathesis, Excluding Mensesactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4036.jsonActive Bleeding or Bleeding Diathesis, Excluding Mensesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4043.jsonDementia and Related Intracranial Pathologiesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4044.jsonAortic Dissection or Ruptured Aortic Aneurysmactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4045.jsonOral Anticoagulant Medicationsactive2023-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4046.jsonCardiopulmonary Emergencyactive2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4047.jsonCardiopulmonary Emergencyactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4048.jsonCardiopulmonary Emergencyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4049.jsonMechanical Circulatory Assist Deviceactive2024-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4050.jsonMechanical Circulatory Assist Deviceactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4052.jsonMechanical Circulatory Assist Deviceactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4053.jsonPregnant Stateactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4054.jsonPregnant Stateactive2024-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4055.jsonPregnant Stateactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3157.4056.jsonMajor Surgical Procedureactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3566.2.1005.jsonChronic Stable Anginaactive2024-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3566.2.1006.jsonChronic Stable Anginaactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.3566.3.1002.jsonChronic Stable Anginaactive2021-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1001.jsonHospice Encounteractive2021-08ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1002.jsonHospice Encounteractive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1003.jsonHospice Encounteractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1004.jsonNutrition Servicesactive2021-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1005.jsonNutrition Servicesactive2021-08ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1006.jsonNutrition Servicesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1007.jsonHospice Care Ambulatoryactive2021-08ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1008.jsonHospice Care Ambulatoryactive2021-08ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1005.jsonOffice Visitactive2023-11ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1020.jsonInitial Hospital Inpatient Visitactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1030.jsonDischarge Services Hospital Inpatient Same Day Dischargeactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1035.jsonDischarge Services Hospital Inpatientactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1040.jsonOutpatient Consultationactive2024-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1050.jsonEmergency Department Evaluation and Management Visitactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1060.jsonNursing Facility Visitactive2024-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1065.jsonDischarge Services Nursing Facilityactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1080.jsonHome Healthcare Servicesactive2024-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1110.jsonPreventive Care, Initial Office Visit, 0 to 17active2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1115.jsonPreventive Care Services Initial Office Visit, 18 and Upactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1120.jsonPreventive Care, Established Office Visit, 0 to 17active2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1125.jsonPreventive Care Services Established Office Visit, 18 and Upactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1130.jsonPreventive Care Services Individual Counselingactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1135.jsonPreventive Care Services Group Counselingactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1215.jsonReferralactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1216.jsonFace-to-Face Interactionactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1221.jsonBehavioral Health Follow up Visitactive2020-03ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1222.jsonPsychotherapy and Pharmacologic Managementactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1228.jsonDetoxification Visitactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1232.jsonAudiology Visitactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1233.jsonMedical Disability Examactive2019-03ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1260.jsonTelephone Visitsactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1261.jsonNursing Facility Visitactive2018-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1262.jsonCare Services in Long Term Residential Facilityactive2018-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1264.jsonOffice Visitactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1265.jsonHome Healthcare Servicesactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1266.jsonOutpatient Consultationactive2020-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1276.jsonFrailty Encounteractive2019-03ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1277.jsonOutpatient Encounteractive2025-03ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1278.jsonOutpatient Encounteractive2025-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1279.jsonFrailty Encounteractive2019-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1284.jsonOutpatient Encounteractive2023-11ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1285.jsonPalliative Encounteractive2025-01ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1286.jsonPalliative Encounteractive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.11.1287.jsonTelephone Visitsactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1001.jsonOffice Visitactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1004.jsonInitial Hospital Inpatient Visitactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1006.jsonDischarge Services Hospital Inpatient Same Day Dischargeactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1007.jsonDischarge Services Hospital Inpatientactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1008.jsonOutpatient Consultationactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1010.jsonEmergency Department Evaluation and Management Visitactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1012.jsonNursing Facility Visitactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1013.jsonDischarge Services Nursing Facilityactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1014.jsonCare Services in Long Term Residential Facilityactive2024-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1016.jsonHome Healthcare Servicesactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1022.jsonPreventive Care Services, Initial Office Visit, 0 to 17active2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1023.jsonPreventive Care Services Initial Office Visit, 18 and Upactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1024.jsonPreventive Care, Established Office Visit, 0 to 17active2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1025.jsonPreventive Care Services Established Office Visit, 18 and Upactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1026.jsonPreventive Care Services Individual Counselingactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1027.jsonPreventive Care Services Group Counselingactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1046.jsonReferralactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1048.jsonFace-to-Face Interactionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1054.jsonBehavioral Health Follow up Visitactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1055.jsonPsychotherapy and Pharmacologic Managementactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1059.jsonDetoxification Visitactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1066.jsonAudiology Visitactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1073.jsonMedical Disability Examactive2021-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1080.jsonTelephone Visitsactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1087.jsonOutpatient Encounteractive2025-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1088.jsonFrailty Encounteractive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.101.12.1090.jsonPalliative Care Encounteractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1010.jsonMultiple Myelomaactive2021-08ushl7icd